pharma · Cancer on the prostatic bed · Prostate cancer at risk of developing metastatic lesions
A.C.O.M. - Advanced
A.C.O.M. - Advanced Center Oncology
A.C.O.M. - Advanced patent portfolio — 1 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- EU
- Programs
- 2
- Drugs
- 4
- Patents
- 1
A.C.O.M. - Advanced patents
1 pharmaceutical patents indexed for A.C.O.M. - Advanced. 1 expire within 24 months.
A.C.O.M. - Advanced has 1 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 1 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
Frequently asked questions
How many patents does A.C.O.M. - Advanced have?
1 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do A.C.O.M. - Advanced patents expire?
1 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.